Advertisement
Advertisement

ALMS

ALMS logo

Alumis Inc. Common Stock

23.66
USD
Sponsored
-0.10
-0.42%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

23.64

-0.02
-0.06%

Alumis Inc. Common Stock Profile

About

Alumis Inc. is a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases. The company's product candidate includes ESK-001. Alumis Inc. is based in SOUTH SAN FRANCISCO, Calif.

Info & Links

CEO

Martin Babler

Headquarters

280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.alumis.com

Auditor

PricewaterhouseCoopers LLP

Share holders

47

Employees

224

Alumis Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

3.01B

Enterprise Value

2.92B

Enterprise Value/EBITDA(ttm)

-6.48

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

121.33

Price to Book(mrq)

7.97

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-1628.99%

Profit Margin(ttm)

-2130.57%

Return on Equity(ttm)

-116.97%

Return on Invested Capital(ttm)

-106.20%

Return on Assets(ttm)

-88.43%

Income Statement

Revenue(ttm)

24.05M

Revenue Per Share(ttm)

0.20

Gross Profit(ttm)

24.05M

EBITDA(ttm)3

-450.31M

Net Income Available to Common(ttm)

-243.32M

Diluted EPS(ttm)

-3.06

Share Statistics

Beta (5Y Monthly)

-0.64

52-Week Change

344.74%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

123.14M

Dividend Yield

0.00%

Float4

75.43M

% Held by Insiders

40.70%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

308.58M

Total Cash Per Share(mrq)

2.51

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.34%

Quick Ratio(mrq)

4.34%

Book Value Per Share(mrq)

2.88

Cash Flow

Operating Cash Flow Per Share(ytd)

-4.35

Free Cash Flow(ytd)

-370.18M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement